| Dr Cinzia Allegrucci |
Cancer epigenetics; cancer stem cells; cancer reprogramming
|
| Dr Kenton Arkill |
Endothelial and vascular biology |
| Prof Dave Barrett |
Metabolomics; cancer biomarkers |
| Prof David Bates |
Growth factors; alternative splicing; chemokines |
| Dr Andrew Benest |
Endothelial cell biology |
| Dr Daniel Booth |
Cancer cell biology |
| Dr Nicole Clarke |
Tumour suppressor IRF1 function; IRF target genes |
| Dr Beth Coyle |
Drug resistance mechanisms in tumours; apoptosis; metastasis; cancer stem cells; pre-clinical models; ependymomas; primitive neuroectodermal tumours; gliomas |
| Dr Cornelia de Moor |
Post-transcriptional regulation of oncogene and tumour suppresor mRNAs; cytokine and growth factor mediated induction of gene expression; polyadenylation as a target in cancer therapy; cordycepin as anti-cancer agent |
| Dr Lodewijk Dekker |
Annexins; anti-tumour agents; POT1 kinase; telomerase inhibitors |
| Dr Marios Georgiou |
Tumour progression; Tumour invasion; drosophila models |
| Dr Anna Grabowska |
Pre-clinical cancer modelling/imaging; target validation; tumour microenvironment |
| Prof David Heery |
Histone acetyltransferases; chromatin modification; nuclear receptors; BCL11A;
PRAME |
| Dr Alistair Hume |
Organelle transport in the cell |
| Dr Victoria James |
Extracellular vesicles, non-coding RNAs, epigenetics and cancer metastasis |
| Dr Sheela Jayaraman |
Gene regulation in vascular biology |
| Dr Jennie Jeyapalan |
Prostate cancer, epigenetics |
| Dr Catherine Jopling |
MicroRNA regulation, complex disease, therapeutics |
| Dr Ian Kerr |
ABC transporters; multidrug resistance in tumours |
| Dr Rajendra Kumari |
Pre-clinical cancer modelling; bioimaging; tumour microenvironment; targeted therapies |
| Dr Srinivasan Madhusudan |
DNA repair; base excision repair; APE1 inhibitors; stratified medicine; cancer clinical trials |
| Dr Stewart Martin |
Prognostic and predictive biomarkers; lymphatic biology and metastasis; radiation biology/radiotherapy; calpains and calpastatin |
| Dr Alan McIntyre |
Molecular and cell biology of the hypoxic tumour microenvironment; tumour metabolism; pH regulation; antiangiogenic therapy |
| Dr Nigel Mongan |
Androgen receptor; Estrogen receptor; REX1/ZFP42; cancer stem cells; prostate cancer |
| Dr Anna Piccinini |
Regulation of gene expression by the extracellular matrix; microRNA; tumour microenvironment |
| Dr Keith Spriggs |
RNA helicase eIF4a; Pdcd4; regulation of mRNA translation |
| Dr Abdolrahman Shams Nateri |
Cancer genetics and stem cell; transcription, signalling and diseases; transgenic mouse models |
| Prof Peter Shaw |
Molecular signalling and gene transcription in cancer; STAT and ETS transcription factors |
| Dr Alex Thompson |
Translational Stem Cell Technology |
| Prof Uwe Vinkemeier |
Interferons in immunity; STAT proteins and cancer immunoediting; molecular basis of inflammation |
| Dr Sebastiaan Winkler |
Post-transcriptional gene regulation; deadenylase enzymes; deadenylase inhibitors; Ccr4-Not; BTG/Tob proteins; leukaemia and lymphoma; breast cancer |